Our findings in human tumor samples that MLKL and RIPK3 gene expression levels were upregulated during ICI treatment suggest a potential positive feedback loop by infiltrating immune cells which might further enhance necroptotic signaling in the TME. Here, RIPK3 is linked to neoplasm.